PATENT CLAIM ANALYSIS

Application Number: 15927553
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-09
Patent Classification: ["514", "008800"]

Abstract:
A method of treating a bone defect is provided. The method comprises administering to the bone defect an injectable solution comprising about 20 μg to about 5000 μg of bone morphogenetic protein-2 (BMP-2) in an aqueous carrier. Kits and methods of making are also provided.

Claim (Index 4):
The method of  claim 1 , wherein the injectable solution further comprises a buffering agent comprising tris(hydroxymethyl)aminomethane (Tris), ethylenediaminetetraacetic acid (EDTA), (2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid) (HEPES), sodium acetate, sodium citrate, sodium phosphate, 2-(N-morpholino)ethanesulfonic acid (MES), phosphate buffered saline (PBS), sodium phosphate, potassium phosphate, sodium chloride, potassium chloride, glycerol, calcium chloride, sucrose, glycine, L-glutamic acid, polysorbate 80 or a combination thereof.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 90.0
- Lexical Diversity: 1.35135
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10937364', '12829540', '12309512', '13458286', '10354856']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7730516894627872
- 35 USC 102 Novelty (BERT): 0.5122208324680021
- Combined Prediction Score: 0.7469686037633088
- Mean Citation Score: 263.41449
- Max Citation Score: 291.8519
- Similarity Product: 198.36612256389265

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test